AnGes MG, Inc.

ANGIOPASS

PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY;ANGIO PASS;

ANGIOZAL

PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY;

COLLATEGENE

Pharmaceutical preparations for use in gene therapy;

COLLATEGENE

In the margin, line 3, should be deleted, and INT. CL.: 5 should be inserted. In the statement, line 7, IN CLASS 3 (U.S. CLS. 1, 4, 6, 50, 51 AND 52) should be deleted, and IN CLASS.: 5 (U.S. CLS. 006, 018, 044, 046, 051 AND 052) should be inserted.;Pharmaceutical preparations for use in gene therapy; and other pharmaceutical preparations for arterial disease, heart disease, cerebrovascular disease, neurological disease, lymphatic disease, skin ulcer or skin grafting;

VASCULAGENE

Pharmaceutical preparations for use in gene therapy;

VASCULAGENE

PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; AND OTHER PHARMACEUTICAL PREPARATIONS FOR ARTERIAL DISEASE, HEART DISEASE, CEREBROVASCULAR DISEASE, NEUROLOGICAL DISEASE, LYMPHATIC DISEASE, SKIN ULCER OR SKIN GRAFTING;VASCULAR GENE;

VENEGENE

PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY;VENE GENE;

VESSELGENE

PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; AND OTHER PHARMACEUTICAL PREPARATIONS FOR ARTERIAL DISEASE, HEART DISEASE, CEREBROVASCULAR DISEASE, NEUROLOGICAL DISEASE, LYMPHATIC DISEASE, SKIN ULCER OR SKIN GRAFTING;VESSEL GENE;

VESSELPASS

PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; AND OTHER PHARMACEUTICAL PREPARATIONS FOR ARTERIAL DISEASE, HEART DISEASE, CEREBROVASCULAR DISEASE, NEUROLOGICAL DISEASE, LYMPHATIC DISEASE, SKIN ULCER OR SKIN GRAFTING;VESSEL PASS;